Page last updated: 2024-09-03

astragaloside a and Fatty Liver, Nonalcoholic

astragaloside a has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Guan, L; Jiang, J; Liu, H; Liu, J; Peng, L; Qiao, Y; Yan, X; Zhai, Y; Zhang, Z; Zhou, W	1

Other Studies

1 other study(ies) available for astragaloside a and Fatty Liver, Nonalcoholic

Article	Year
Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 107 Topics: Animals; Bile Acids and Salts; Ceramides; Diet, High-Fat; Fibroblast Growth Factors; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Intestines; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; RNA, Ribosomal, 16S; Saponins; Sterols; Triterpenes	2022

Article

Year

Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 107

Topics: Animals; Bile Acids and Salts; Ceramides; Diet, High-Fat; Fibroblast Growth Factors; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Intestines; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; RNA, Ribosomal, 16S; Saponins; Sterols; Triterpenes

2022